InBody Co

InBody Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of InBody Co (041830.KQ) as of Oct 26, 2026 is 11.36. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 11.37 — a change of -0.04% (lower).

EV/EBIT

11.36

YoY

-0.04%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of InBody Co is 2025 11.36 . EV/EBIT (Enterprise Value to EBIT) of InBody Co was 2024 11.37 . It decreases by -0.04% lower compared to the previous year.

The InBody Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
15.23 KRW
Jan 1, 2020
21.87 KRW
Jan 1, 2021
11.65 KRW
Jan 1, 2022
10.26 KRW
Jan 1, 2023
10.89 KRW
Jan 1, 2024
11.37 KRW
Jan 1, 2025
11.36 KRW
Jan 1, 2026 (e)
9.38 KRW
The InBody Co EV/EBIT history
YEAREV/EBITYoY
est9.38-17.44%
11.36-0.04%
11.37+4.38%
10.89+6.13%
10.26-11.91%
11.65-46.73%
21.87+43.62%
15.23-13.67%
17.64+5.17%
16.77-12.27%
19.11-8.42%
20.87-49.54%
41.36+120.73%
18.74+15.47%
16.23-63.38%
44.32+444.47%
8.14+19.53%
6.81+6.24%
6.41-51.18%
13.13-79.88%
65.25—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

InBody Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides InBody Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates InBody Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots InBody Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if InBody Co grows earnings faster than its peers.

InBody Co Stock analysis

What does InBody Co do? InBody Co., Ltd. generates revenue through the sale of body composition analyzers under the InBody and Lookin’Body brand names. The InBody series includes models such as InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10, and InBody J10, while the Lookin’Body series offers Lookin’Body3.0 and Lookin’Body Basic for measuring proteins, minerals, fats, and moisture. The company also sells BMI measuring devices under the BSM brand. Products are distributed domestically and internationally to meet demand in both markets. The primary customers for InBody’s equipment are healthcare facilities, fitness centers, and wellness providers seeking accurate body composition data. The InBody series targets professional and clinical settings, whereas Lookin’Body products cater to general wellness and fitness applications. BSM devices serve as complementary tools for body mass index tracking in similar environments. InBody Co., Ltd. focuses on selling medical equipment directly to end-users and distributors, with no mention of third-party partnerships or additional revenue streams. The company’s product portfolio is designed to address diverse needs within the health and fitness industry, leveraging its established brand names for market penetration. InBody Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InBody Co stock

EV/EBIT (Enterprise Value to EBIT) of InBody Co is 11.36 in 2025.

EV/EBIT (Enterprise Value to EBIT) of InBody Co changed from 11.37 to 11.36, representing a -0.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) InBody Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s InBody Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — InBody Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — InBody Co